Blood pressure | Page 54 of 72

Ageing :: Calorie restriction – a prescription that extend life

The approach, called calorie restriction, involves eating about 30 percent fewer calories than normal while still getting adequate amounts of vitamins, minerals and other nutrients. Aside from direct genetic manipulation, calorie restriction is the only strategy known to extend life consistently in a variety of animal species, a report of study in a laboratory at the Wisconsin National Primate Research Center, highlighted by Michael Mason in the New York Times.

Stress :: Managing stressful life with better lifestyle

As we all know, life is very stressful these days, specially in corporate sector. People work more, skip meals and miss sleep. Everyone is trying to achieve the targets, and then result is stress. In stress, mind grows all the negative thoughts like fear, anger, guilt, anxiety, frustration, and so on. And in response to all these, body produces catecholamines which results in increased acidity, faster beating of hearts, tensing of muscles, shooting of blood pressure and restless mind. Finally, all these end up with hypertension, thyroid problems, diabetes mellitus, and many other chronic diseases.

ADHD :: Lilly’s Strattera, atomoxetine effective in treating ADHD in children and adolescents

New data suggest that Strattera? (atomoxetine HCl) improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder, like dyslexia. Results were announced at a meeting of child and adolescent psychiatrists.

Health :: Racial discrimination a key factor in African-American health disparities

The experience of racial discrimination may be a key factor in explaining why African Americans have higher rates of obesity and suffer at higher rates from such diseases as diabetes and cardiovascular disorders, according to UCLA researchers. Repeated responses to such discrimination — which include elevated blood pressure and heart rate — can cause enormous stress on a person’s mental and physical health, according to research scheduled to be published in Volume 58 of the Annual Review of Psychology.

Hypertension :: Results of TROPHY study on hypertension are misleading

There may be as many as 70 million Americans with prehypertension. If these people can be treated pharmacologically to avoid or delay progression to clinical hypertension, there would be significant benefits to them and the overall health of the population. The recent TROPHY study seems to lead to that conclusion. However, two editorials published in the November issue of the American Journal of Hypertension emphatically argue that the study is flawed and the conclusions reached are misleading.

ADHD :: Daytrana, methylphenidate transdermal system provides individualized ADHD symptom management

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. The ability to remove the patch earlier than the recommended nine-hour wear time allows physicians the opportunity to manage the potential for late-day side effects, such as lack of appetite or difficulty sleeping. These phase IIIb clinical trial results were reported today at a major scientific and educational meeting of child and adolescent psychiatrists in San Diego, Calif.

Exercise :: Walking not enough for significant exercise benefits

Walking is a popular form of exercise, but may not be enough to experience significant health benefits, a University of Alberta study shows. “Generally, low-intensity activity such as walking alone is not likely going to give anybody marked health benefits compared to programs that occasionally elevate the intensity,” said Dr. Vicki Harber, lead author on the Health First study, which was presented recently at the American College of Sports Medicine annual conference.

Pregnancy :: Philips triplets monitoring with its Avalon fetal monitors

Royal Philips (NYSE: PHG, AEX: PHI) announced the availability of triplets monitoring functionality for its industry-leading line of obstetrical care fetal and maternal monitors, Avalon FM20 antepartum and Avalon FM30 intrapartum. Philips is the first company to introduce a fetal monitor that enables non-invasive triplets monitoring with a single device.

Pregnancy :: Uterine blood flow during supine rest and exercise after 28 weeks of gestation

To test the null hypothesis that, after 28 weeks of gestation, uterine blood flow during supine rest and supine exercise is no different than uterine blood flow at left-lateral rest, RM Jeffreys,a W Stepanchak,a B Lopez,a,b J Hardis,a JF Clapp IIIa,b,c conducted study in pregnant women at Department of Obstetrics, MetroHealth Medical Center, Cleveland, OH, USA.

Heart Disease :: GlaxoSmithKline’s COREG, carvedilol phosphate for cardiovascular conditions

GlaxoSmithKline (NYSE: GSK) and Flamel Technologies (NASDAQ:FLML) announced FDA approval of once-a-day Coreg CR (carvedilol phosphate) extended-release capsules, for the treatment of three cardiovascular conditions: 1. High blood pressure, also known as hypertension. 2. A heart attack that has reduced how well the heart pumps (known medically as post-myocardial infarction left ventricular dysfunction). 3. Mild to severe heart failure.